loader2
Partner With Us NRI

Company details

69.65
77.10
38.65
82.00
6M Return 15.21%
1Y Return 61.21%
Mkt Cap.(Cr) 146.51
Volume 8,871
Div Yield 0.71%
OI
-
OI Chg %
-
Volume 8,871

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 52.70 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 1,077.60 36,508.33
LAST 3M 38,231.60 5,545.35
LAST 6M 121,291.29 -142,349.22
LAST 12M 212,636.06 -215,172.33

Information

  • About Company
  • Company Info
  • Listing Info
32.05
57.74%
26.2548
4.03%
3.02%
Description
  • The Company was originally incorporated as `Kalaivani Health Centre Pvt. Limited` on 14/03/1997. The company name was changed to `Lotus Eye Care Hospital Pvt. Limited` on 23/01/2006. Dr S.K.Sundaramoorthy has promoted the company. Lotus Eye Care Hospital is the state of art eye care hospital group successfully functioning in South India with specialization in super-specialty service related to eye care. Lotus has two centers in Coimbatore, one in down town and another in civil aerodrome inaugurated in the year 2002. The Salem center is located in the heart of the city and it was started in the year 2004. The Tirupur center started in 2007 is also functioning in prime location in the city. These hospitals have hi-tech eye care equipments and ophthalmic experts backed by well-trained paramedical and administrative team. All the centers have fully computerized modern setup manned by medical and administrative staff. The network of eye care hospitals has 9 operation theatres and 3 lasik laser equipments. Most of the eye operations are performed as a day care procedure and therefore the company has maintained optimum number of beds. The hospitals total bed strength of all the centers is 120 beds excluding eye camp beds. In the year 1998, Lotus introduced Multi Scan Lasik and in the year 2002 Wave front based Esiris Custom Lasik for the first time in India. Lotus was the first Eye hospital in South East Asia to have Epilasik in July 2004. In the year June 2005 Lotus introduced the most advanced technology of Zyoptix and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve supervision. In the year 2006-2007, Dr. S.K.S.Eye Care Centre Pvt. Ltd., (Dr S K Sundaramoorthy promoter of the company) was merged with company w.e.f. 01/12/2006.

Read More

Registered Address

SF No770/12 Civil Aerodrome(P), Avinashi Road, Coimbatore, Tamil Nadu, 641014

Tel : 91-0422 4229900
Email : lotussecdept:gmail.com
Website : http://www.lotuseye.org

Registrar

SKDC Consultants Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 532998
NSE Code : LOTUSEYE
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE947I01017

ICICIdirect Lotus Eye Hospital & Institute Ltd FAQ

You can buy Lotus Eye Hospital & Institute Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Lotus Eye Hospital & Institute Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Aug 12, 2022 04:01 PM the closing price of Lotus Eye Hospital & Institute Ltd was ₹ 70.45.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Aug 12, 2022 04:01 PM, the market cap of Lotus Eye Hospital & Institute Ltd stood at ₹ 146.51.
The latest PE ratio of Lotus Eye Hospital & Institute Ltd as of Aug 12, 2022 04:01 PM is 32.05
The latest PB ratio of Lotus Eye Hospital & Institute Ltd as of Aug 12, 2022 04:01 PM is 0.37
The 52-week high of Lotus Eye Hospital & Institute Ltd is ₹ 82.00 while the 52-week low is ₹ 38.65 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE